194 related articles for article (PubMed ID: 24962028)
1. TRIB1 supports prostate tumorigenesis and tumor-propagating cell survival by regulation of endoplasmic reticulum chaperone expression.
Mashima T; Soma-Nagae T; Migita T; Kinoshita R; Iwamoto A; Yuasa T; Yonese J; Ishikawa Y; Seimiya H
Cancer Res; 2014 Sep; 74(17):4888-97. PubMed ID: 24962028
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
[TBL] [Abstract][Full Text] [Related]
3. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer.
Pootrakul L; Datar RH; Shi SR; Cai J; Hawes D; Groshen SG; Lee AS; Cote RJ
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5987-93. PubMed ID: 17062670
[TBL] [Abstract][Full Text] [Related]
4. Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78.
Tsai HY; Yang YF; Wu AT; Yang CJ; Liu YP; Jan YH; Lee CH; Hsiao YW; Yeh CT; Shen CN; Lu PJ; Huang MS; Hsiao M
Oncogene; 2013 Oct; 32(41):4921-31. PubMed ID: 23318453
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development.
Dong D; Ni M; Li J; Xiong S; Ye W; Virrey JJ; Mao C; Ye R; Wang M; Pen L; Dubeau L; Groshen S; Hofman FM; Lee AS
Cancer Res; 2008 Jan; 68(2):498-505. PubMed ID: 18199545
[TBL] [Abstract][Full Text] [Related]
6. Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells.
Niespolo C; Johnston JM; Deshmukh SR; Satam S; Shologu Z; Villacanas O; Sudbery IM; Wilson HL; Kiss-Toth E
Front Immunol; 2020; 11():574046. PubMed ID: 33329538
[TBL] [Abstract][Full Text] [Related]
7. Frequently rearranged in advanced T‑cell lymphomas‑1 demonstrates oncogenic properties in prostate cancer.
Zhang W; Xiong H; Zou Y; Xu S; Quan L; Yuan X; Xu N; Wang Y
Mol Med Rep; 2016 Oct; 14(4):3551-8. PubMed ID: 27599661
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor TFII-I causes transcriptional upregulation of GRP78 synthesis in prostate cancer cells.
Misra UK; Wang F; Pizzo SV
J Cell Biochem; 2009 Feb; 106(3):381-9. PubMed ID: 19097122
[TBL] [Abstract][Full Text] [Related]
9. Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.
Kobayashi T; Shimizu Y; Terada N; Yamasaki T; Nakamura E; Toda Y; Nishiyama H; Kamoto T; Ogawa O; Inoue T
Prostate; 2010 Jun; 70(8):866-74. PubMed ID: 20127734
[TBL] [Abstract][Full Text] [Related]
10. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
[TBL] [Abstract][Full Text] [Related]
11. TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK/Src and ERK pathways.
Wang Y; Wu N; Pang B; Tong D; Sun D; Sun H; Zhang C; Sun W; Meng X; Bai J; Chen F; Geng J; Fu S; Jin Y
Oncotarget; 2017 Jul; 8(29):47931-47942. PubMed ID: 28624785
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum protein 29 (ERp29): An emerging role in cancer.
Zhang D; Richardson DR
Int J Biochem Cell Biol; 2011 Jan; 43(1):33-6. PubMed ID: 20920593
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
Al-Hashimi AA; Lebeau P; Majeed F; Polena E; Lhotak Š; Collins CAF; Pinthus JH; Gonzalez-Gronow M; Hoogenes J; Pizzo SV; Crowther M; Kapoor A; Rak J; Gyulay G; D'Angelo S; Marchiò S; Pasqualini R; Arap W; Shayegan B; Austin RC
J Biol Chem; 2017 Dec; 292(51):21180-21192. PubMed ID: 29066620
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells.
Zhang B; Xiao HJ; Chen J; Tao X; Cai LH
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):219-24. PubMed ID: 21625267
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.
Tsui KH; Chang YL; Feng TH; Chang PL; Juang HH
Prostate; 2012 Sep; 72(13):1431-42. PubMed ID: 22290289
[TBL] [Abstract][Full Text] [Related]
16. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
Fu Y; Li J; Lee AS
Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
[TBL] [Abstract][Full Text] [Related]
17. TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.
Liu ZZ; Han ZD; Liang YK; Chen JX; Wan S; Zhuo YJ; Cai ZD; Deng YL; Lin ZY; Mo RJ; He HC; Zhong WD
Cell Signal; 2019 Jul; 59():152-162. PubMed ID: 30926388
[TBL] [Abstract][Full Text] [Related]
18. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.
Daneshmand S; Quek ML; Lin E; Lee C; Cote RJ; Hawes D; Cai J; Groshen S; Lieskovsky G; Skinner DG; Lee AS; Pinski J
Hum Pathol; 2007 Oct; 38(10):1547-52. PubMed ID: 17640713
[TBL] [Abstract][Full Text] [Related]
19. Grp78 is essential for 11-deoxy-16,16-dimethyl PGE2-mediated cytoprotection in renal epithelial cells.
Jia Z; Person MD; Dong J; Shen J; Hensley SC; Stevens JL; Monks TJ; Lau SS
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1113-22. PubMed ID: 15226156
[TBL] [Abstract][Full Text] [Related]
20. Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy.
Lin JA; Fang SU; Su CL; Hsiao CJ; Chang CC; Lin YF; Cheng CW
Urol Oncol; 2014 Jan; 32(1):29.e1-11. PubMed ID: 23428538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
